Novartis cancer drug beating path to NHS
October 17, 2014Sales and Marketing GIST, Glivec, NHS, NICE, imatinib, uturn
NICE has issued final draft guidance recommending Novartis’s Glivec for up to three years in people who have had a …
Four promotions at Red Door Communications
October 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kate Aldous, Katy Pogson, Matt Lowe, Red Door Communications, Sarah Aldridge
Red Door Communications (RDC) has promoted Matt Lowe and Katy Pogson to its board of directors, and Kate Aldous and …
New cancer drugs escalate Roche earnings
October 16, 2014Research and Development, Sales and Marketing Cancer, Herceptin (trastuzumab), Kadcyla, Perjeta, Q3, Roche, ado-trastuzumab emtansine, pertuzumab
Roche’s sales saw solid growth in the first nine months of the year, increased by the firm’s new cancer medicines. …
AstraZeneca deepens Cambridge ties
October 16, 2014Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, CRUK, Cambridge, MRC, MedImmune
AstraZeneca along with its biologics R&D arm MedImmune are to enter into four new collaborations with the University of Cambridge. …
Boehringer and Roche IPF drugs win FDA approval
October 16, 2014Research and Development, Sales and Marketing Boehringer, ERS, Esbriet, FDA, IPF, InterMune, Roche, US, lung scarring, lungs, ofev
The FDA has approved both Roche’s Esbriet (pirfenidone) and Boehringer Ingelheim’s Ofev (nintedanib) for the treatment of the fatal lung …
NICE not recommending Dendreon cancer vaccine
October 16, 2014Sales and Marketing Dendreon, NHS, NICE, Provenge, sipuleucel-T, therapeutic cancer vaccine
NICE has issued preliminary draft guidance not recommending Dendreon’s therapeutic cancer vaccine Provenge for prostate cancer in people whose disease …
Novo Nordisk hires human resources VP
October 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jackie Scanlan, Novo Nordisk
Novo Nordisk has appointed Jackie Scanlan to join its executive team as the corporate vice president of its human resources …
AbbVie reconsiders Shire deal over tax laws
October 15, 2014Medical Communications, Sales and Marketing AbbVie, Abbott, Obama, Shire, US, mergers, tax
AbbVie will reconsider its planned $54.6 billion takeover of Shire in light of new US proposals designed to curb companies …
BT and Exostar partner on research software
October 15, 2014Medical Communications, Research and Development, Sales and Marketing BT, cloud, exostar, iam, life sciences, software, workbench
Cloud computing company Exostar has become a partner of BT for Life Sciences, allowing its Identity and Access Management (IAM) …
Telescope implant for macular degeneration approved
October 15, 2014Medical Communications, Sales and Marketing FDA, VisionCare Ophthalmic Technologies, macular degeneration, telescope implant
Medical device development firm VisionCare Ophthalmic Technologies has had its implantable miniature telescope for age-related macular degeneration disease approved by …
FDA approves Eisai’s chemo side-effects drug
October 15, 2014Research and Development, Sales and Marketing Eisai, FDA, Helsinn, akynzeo, chemotherapy, cinv
Eisai and Helsinn Healthcare’s Akynzeo (netupitant/palonosetron) has received FDA approval for the treatment of chemotherapy-induced nausea and vomiting (CINV). CINV …
Scottish Lifesciences Association welcomes chair
October 15, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ken Sutherland, Scottish Lifesciences Association
The Scottish Lifesciences Association has named Dr Ken Sutherland as its new chair. Sutherland joins from Toshiba Medical Visualisation Systems …
Have you been tempted to translate online?
October 14, 2014The need to communicate across the world is growing every day and with it the demand for translation services, particularly …
BMS, Pharmacyclics and Janssen collaborate on cancer
October 14, 2014Research and Development, Sales and Marketing BMS, Janssen, Pharmacyclics, imbruvica, opdivo
Bristol-Myers Squibb, Pharmacyclics and Janssen are to collaborate on clinical trials combining BMS’s cancer drug Opdivo (nivolumab) with Janssen and …
Chinese military-linked firm says it has Ebola cure
October 14, 2014Medical Communications, Sales and Marketing Ebola, WHO, amms, brincidofovir, sihuan pharmaceutical holdings, tekmira, zmapp
A Chinese drugmaker that has close military ties is seeking fast-track approval for its JK-05 drug that it says can …
NICE releases ‘person-centred’ medicines optimisation guidelines
October 14, 2014Research and Development, Sales and Marketing ABPI, NHS, NICE, UK, WHO, Whitehead
NICE has recently released the draft of its first guidance on medicines optimisation that it hopes will be more person-centered …
Pfizer breast cancer pill gets FDA nod
October 14, 2014Research and Development, Sales and Marketing FDA, Femera, LEE011, Pfizer, bemaciclib, breast cancer, palbociclib
Pfizer’s experimental breast cancer drug palbociclib has been accepted and granted a priority review by the US Food and Drug …
Havas Life Medicom recruits from Pan
October 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jon Linscott, Pan, havas life medicom
Healthcare comms firm Havas Life Medicom has appointed Jon Linscott to its team to serve as a senior director. Linscott …
Hospira recalls drug due to storage hiccup
October 13, 2014Manufacturing and Production, Sales and Marketing FDA, Hospira, Vancocin, Vancomycin hydrochloride, lilly
Hospira has issued a recall of one lot of its injectable vancomycin hydrochloride in the US due to ‘uncontrolled storage …
Steris to buy UK’s Synergy Health for $1.9 billion
October 13, 2014Manufacturing and Production, Sales and Marketing health, manufacturing, steris, synergy, tax
US-based medical technology firm Steris Corporation is to purchase Synergy Health in the UK for $1.9 billion and will shift …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
